X. Lucas Lu
Papers
1
Total Citations
42
H-Index
1
About
X. Lucas Lu is a leading researcher in cancer biomarker discovery and translational oncology, with a primary focus on identifying blood-based diagnostic tools for breast cancer. His major contributions center on leveraging proteomic technologies to detect molecular signatures that differentiate cancer subtypes and monitor therapeutic responses. In his seminal 2006 study, Lu demonstrated that declining plasma fibrinogen alpha fragment levels can identify HER2-positive breast cancer patients, a finding that holds promise for developing a simple, non-invasive blood test to complement radiological screening. This work, which has garnered over 42 citations, addresses a critical gap in early detection and shows that these biomarkers revert to normal levels after surgery, underscoring their potential for monitoring treatment efficacy. Lu’s research bridges proteomics and clinical application, offering a pathway toward more sensitive, accessible diagnostics. His achievements highlight a commitment to translating molecular insights into practical tools that could improve outcomes for women with breast cancer, making his work highly relevant for students and researchers interested in cancer biology, precision medicine, and biomarker validation.
Research Focus
Key Achievements
Top Papers
- 1